Announced
Completed
Decheng Capital led a $102m Series A round in Baylor Genetics.
Synopsis
Decheng Capital, an investment firm, led a $102m Series A round in Baylor Genetics, a diagnostic genomics company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite